Note: Ingredients listed on restricted chemical lists
EC/CAS
26447-40-5
Name of the chemical
Methylenediphenyl diisocyanate (see also specific isomers)
Concentration
N/A
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
N/A
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
N/A
EC/CAS
6846-50-0
Name of the chemical
2,2,4-trimethyl-1,3-pentanediol diisobutyrate
Concentration
N/A
General Information
Revision date
2008-11-13
Product name
FlexFoam
Icons in SDS
Company Information
company name
CME, LLC
Section 2
Potential health effects
Eyes: Liquids, vapors, or mists are irritating to the eyes and can cause stinging, burning, lachrymation or tearing. Skin: Moderate irritant. Repeated and/or prolonged contact may cause skin sensitization. Ingestion: Ingestion may cause irritation of the gastrointestinal tract and gastrointestinal discomfort with any or all of the following symptoms: nausea, vomiting, lethargy, or diarrhea. Inhalation: Inhalation of vapors or mist at concentrations above the TLV can cause respiratory tract irritation. (Nose, throat, lungs.) Chronic inhalation can result in sensitization. Signs and Symptoms of Overexposure Eyes: Contact may cause moderate irritation consisting of transient redness, swelling, and mucous membrane discharge to the conjunctiva. Prolonged contact with the eyes may cause reversible corneal opacity to occur, with no visual impairment expected. Skin: Contact may cause minor irritation consisting of transient redness and/or swelling. Individuals with skin sensitization can develop these symptoms from contact with a small amount of liquid or vapors. CME FlexFoam 04/16/08 1 of 7 Ingestion: Ingestion may cause irritation of the gastrointestinal tract and gastrointestinal discomfort with any or all of the following symptoms: nausea, vomiting, lethargy or diarrhea. Inhalation: Vapors or mist, especially as generated from heating the material or as from exposure in poorly ventilated areas or confined spaces, are irritating and cause nasal discharge, coughing, discomfort in nose and throat, and breathing obstruction. Individuals with respiratory sensitization may experience allergic respiratory reactions when exposed to amounts below the exposure guidelines.
Medical Conditions Generally Aggravated by Exposure
Asthma, other respiratory disorders (bronchitis, emphysema, bronchia hyperreactivity), skin allergies, eczema.
Principle Routes of Exposure
Inhalation, skin contact, eye contact, ingestion Sensitization : Any individual with isocyanate sensitization should not be exposed to this product. These individuals can react to exposure well below the TLV. Symptoms can occur immediately or several hours after exposure. ---------------------------Section IV –First Aid Measures------------------------
